# Travv

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/travv

- Industry: Healthcare IT
- Headquarters: Stillwater, US
- Website: www.travv.com
- Total disclosed funding: $1.6M
- Latest round: Seed (May 6, 2026)
- Investors on record: 2

## About

Based in the US, Travv, Inc. specializes in artificial intelligence-driven veterinary diagnostics, enhancing traditional procedures to improve the accuracy and efficiency of animal healthcare services. Cofounded in 2025 in Stillwater, US, by Derick Whitley CEO , Tony Pease, Zachary Runyan. Travv, Inc. delivers advanced veterinary diagnostics using AI technology. In May 2026, Travv, Inc. raised USD 1.6 million in seed funding led Digitalis Ventures, Ani.vc. The sole deal to date reflects the company’s growing focus on innovation in veterinary services. Travv specializes in advanced veterinary diagnostics through a modern, integrated platform that harnesses artificial intelligence (AI) to enhance traditional procedures such as radiology and pathology. The company's core offerings include a suite of cloud-based diagnostic tests designed to streamline workflows for veterinarians and provide them with expert diagnostic support. By leveraging high-fidelity datasets curated by domain experts, Travv aims to improve diagnostic accuracy and efficacy in veterinary healthcare. The products are targeted towards global veterinarians and diagnostic professionals, facilitating enhanced patient care across various regions, including North America, Europe, and parts of Asia. As Travv continues to innovate, its services are positioned to meet the evolving needs of an expanding customer base that includes private veterinary practices, animal hospitals, and specialty clinics.Travv, Inc.
 generates revenue through a subscription-based model, wherein veterinary practices and diagnostic facilities can access its suite of cloud-based diagnostic services. Clients typically engage in annual or monthly subscription plans that offer tiered access to various AI-powered diagnostic tools and resources. This business model is structured to support both individual practitioners and larger veterinary organizations, fostering a B2B relationship with its clientele. Specific pricing plans are developed around the breadth of services utilized, allowing customers to tailor their subscriptions according to their diagnostic needs. By establishing such a framework, Travv positions itself to create steady revenue streams while enhancing customer loyalty and satisfaction within the veterinary diagnostics market.Following the USD 1.6 mn Seed funding raised in May 2026, Travv, Inc. intends to further develop and expand its artificial intelligence veterinary diagnostics platform. The funding will support product growth, onboarding, and integrations, enabling the company to enhance its service offerings. Travv plans to launch new products tailored to the needs of veterinarians by the end of 2026 and aims to broaden its reach into new geographic markets, specifically targeting Asia and Europe within the next 18 months.

## Funding rounds

- Seed, May 6, 2026, $1.6M — Digitalis Ventures, Ani.vc

## Investors

- Digitalis Ventures (https://capitalatlas.ai/funds/digitalis-ventures) — Seed
- Ani.vc (https://capitalatlas.ai/funds/ani-vc) — Seed